A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Effectiveness and Safety of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia: an Observational Study
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
2,000 participants
Feb 12, 2025
OBSERVATIONAL
Conditions
Summary
Data on the real-world use and effectiveness and safety of bempedoic acid combined with both a statin and ezetimibe in clinical practice is limited. There is an increased focus on using combination therapy to lower LDL-C.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No drug was administered in this observational study.
No drug was administered in this observational study.
No drug was administered in this observational study.
No drug was administered in this observational study.
Locations(163)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06686615